DEA proposes listing three steroids under Schedule III
The Drug Enforcement Administration is proposing to classify three steroids as Schedule III controlled substances to avoid the potential for drug abuse and trafficking. The three steroids are: boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione. DEA said currently these steroids are not approved for medical use. However, there are some companies, primarily Internet- and China-based, that are selling them. This proposal, if approved, will bar the importation, exportation, and sale of these substances except for legitimate research or industrial uses. Those who wish to comment on this proposal should send them in by June 24.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
MORE ARTICLES IN THIS ISSUE
A Miami pharmacy owner has been convicted of defrauding Medicare.
A new dosage form of once per month is now available for the osteoporosis drug Actonel.